{
    "clinical_study": {
        "@rank": "75699", 
        "biospec_descr": {
            "textblock": "1. Collection of venous blood, pretreatment of blood sample, take the plasma and\n           erythrocyte respectively.\n\n        2. Collection of breast milk (only for women having lactated for 42\u00b17 days)"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "This is a multi-center, cross-sectional, non-interventional, observational study\u2014\u2014an\n      investigation carried out in 816 pregnant (pregnant week 17\u00b12 group and pregnant week 39\u00b12\n      group; 408 cases in each group) and 408 lactating women (post-natal lactation day 42\u00b17\n      group) from a total of 4 sites in 3 typical areas (1 coastal regions, 2 inland regions and 1\n      lake regions) in China to study the correlation between DHA intake and DHA concentrations in\n      blood and breast milk."
        }, 
        "brief_title": "Investigation of DHA Intake in Pregnant and Lactating Women in China", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Nutrient Intake Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Eating Disorders", 
                "Nutrition Disorders"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a multi-center, cross-sectional, non-interventional, observational study in 816\n      pregnant (gestation week 17\u00b12 group and gestation week 39\u00b12 group 408 cases in each group)\n      and 408 lactating women (post-natal lactation day 42\u00b17 group) from a total of 4 sites in 3\n      typical areas (1 coastal regions, 2 inland regions and 1 lake regions) in China to study the\n      correlation between DHA intake and DHA concentrations in blood and breast milk.\n      Investigators are mainly physicians majoring in gynaecology and obstetrics, etc. During\n      visits, the study physician will record the patient's social demographic data, disease and\n      relevant medication history, review her medical records, assess DHA intake by the DHA\n      Screener, and determine DHA concentrations in erythrocyte membrane, plasma and breast milk,\n      so as to validate the feasibility of DHA Screener as  DHA intake assessment tool for\n      determining DHA concentrations in the body.\n\n      Subjects meeting inclusion criteria and non of the exclusion criteria will be informed of\n      relevant information of the study. Subjects should  be voluntarily consent to participate in\n      the study and sign the informed consent form.\n\n      Screening of the study is scheduled for as long as 5 months. In this study, additional\n      examinations or other interventions are not required."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        PREGNANT WOMEN:\n\n          -  Healthy women presenting at their week 17\u00b12 and week 39\u00b12 obstetric examination;\n\n          -  18-40 years of age;\n\n          -  Monocyesis;\n\n          -  Having signed the informed consent form voluntarity before participating in the\n             study.\n\n        LACTATING WOMEN:\n\n          -  Healthy women presenting at their day 42\u00b17 post-natal visit;\n\n          -  18-40 years of age;\n\n          -  Monocyesis;\n\n          -  Having signed the informed consent form voluntarily before participating in the study\n\n        Exclusion Criteria:\n\n          -  Administration of DHA supplements  (milk powder for pregnant women, DHA soft capsule,\n             Zmarto, NURIZ, Naturies,  HeadDHA, Beibeicong, Nutrimed etc);\n\n          -  Still experiencing severe vomiting after 16 weeks of pregnancy;\n\n          -  Women who have  heart, liver, kidney, (ALT and AST\u2265 1.5 times of normal upper limit,\n             Cr>normal upper limit) or severe lung disease or laboratory abnormality (i.e.lipid\n             metabolism disorder) that may interfere with the interpretation of study results, as\n             indicated in previous examinations;\n\n          -  Pregnant woman currently participating in other clinical trials or who have\n             participated in another clinical trial in the last 30 days;\n\n          -  Women who in the judgement of the investigator cannot be expected to comply with the\n             protocol or study procedures."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "816 pregnant (pregnant week 17\u00b12 group and pregnant week 39\u00b12 group; 408 cases in each\n        group) and 408 lactating women (post-natal lactation day 42\u00b17 group)"
            }
        }, 
        "enrollment": {
            "#text": "1224", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02104544", 
            "org_study_id": "14.10.CN.INF"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "DHA intake;", 
            "Plasma;", 
            "Erythrocyte;", 
            "Breast milk."
        ], 
        "lastchanged_date": "April 8, 2014", 
        "number_of_groups": "1", 
        "official_title": "Investigation of DHA Intake in Pregnant and Lactating Women in China", 
        "other_outcome": {
            "description": "To assess the correlation between DHA intake and DHA concentrations in the blood and breast milk of lactating women", 
            "measure": "To assess the correlation between DHA intake and DHA concentrations in the blood and breast milk of lactating women", 
            "safety_issue": "No", 
            "time_frame": "5 months"
        }, 
        "overall_contact": {
            "email": "liujm@pku.edu.cn", 
            "last_name": "Jianmeng Liu, Doctor", 
            "phone": "13911460833"
        }, 
        "overall_contact_backup": {
            "email": "hongtian821207@126.com", 
            "last_name": "Hongtian Li, Mastor", 
            "phone": "18600003037"
        }, 
        "overall_official": {
            "affiliation": "Peking University", 
            "last_name": "Jianmeng Liu, Doctor", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Correlation between DHA Screener and DHA concentration in plasma; Correlation between DHA Screener and DHA concentration in erythrocyte membrane; Correlation between DHA Screener and DHA concentration in breast milk.", 
            "measure": "To evaluate the feasibility in using DHA Screener for determination of internal DHA concentration", 
            "safety_issue": "No", 
            "time_frame": "5 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02104544"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Peking University", 
            "investigator_full_name": "Liu Jianmeng", 
            "investigator_title": "The Institute of Reproductive and Child Health", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "To assess correlation between DHA Screener assessment tool and RBC DHA among study groups;\nTo compare DHA intake assessed by DHA Screener against Chinese recommendations of DHA intake.", 
                "measure": "To compare the correlation between DHA Screener and RBC DHA among different subgroups. To compare DHA intake assessed by DHA Screener against Chinese recommendations of DHA intake.", 
                "safety_issue": "No", 
                "time_frame": "5 months"
            }, 
            {
                "description": "To compare DHA intake assessed by DHA Screener against Chinese recommendations of DHA intake.", 
                "measure": "To compare DHA intake assessed by DHA Screener against Chinese recommendations of DHA intake.", 
                "safety_issue": "No", 
                "time_frame": "5 months"
            }
        ], 
        "source": "Peking University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Peking University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Cohort", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}